|
Market Cap (17-May) $14,687,399 (777th) |
Close (30-Jun) $0.018 |
Volume (30-Jun) 1,123,417 |
Shortsold (11-Sep) 1,800,000 (0.12%) (439th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E 20.00 |
EPS -0.02 |
BNO released this announcement to the ASX on 19 December 2022, 10:01. The announcement is marked as price sensitive, and is 3 page(s) in length and 108.04kb in size.
You can view all announcements from BNO and see how they appear on a price chart on the announcements page.
At the date of this announcement, BNO was 0.031% short sold according to ASIC data. It was ranked the 536th most shorted stock on the ASX. It is now ranked as the 439th most shorted stock on the ASX with 0.123% of total shares short sold as of the latest reported data (11 September 2023).
| Other Recent Announcements from BNO | |
|---|---|
| Poster Presentation at the ASCP Annual Meeting | 1 June 2023, 9:16 |
| Corporate Presentation - May 2023 | 23 May 2023, 9:24 |
| BNO announces establishment of At-The-Market Equity Program | 8 May 2023, 8:54 |
| BNO Reports Topline Results in PREVAIL Phase2 Study BNC210 | 19 December 2022, 10:01 |
| Proposed issue of securities - BNO | 16 December 2022, 15:23 |
| BNO appoints Dr. Spyros Papapetropoulos as President and CEO | 16 December 2022, 9:19 |
| Change of Director's Interest Notice DW | 28 November 2022, 18:32 |
You must be logged in to post a reply.
Bionomics 